<!DOCTYPE html>
<html lang="" xml:lang="">
  <head>
    <title>Dynamism and Complexity in Immune Ecology</title>
    <meta charset="utf-8" />
    <meta name="date" content="2022-02-01" />
    <script src="libs/header-attrs/header-attrs.js"></script>
    <script src="libs/kePrint/kePrint.js"></script>
    <link href="libs/lightable/lightable.css" rel="stylesheet" />
    <link rel="stylesheet" href="xaringan-themer.css" type="text/css" />
    <link rel="stylesheet" href="xaringan-custom.css" type="text/css" />
  </head>
  <body>
    <textarea id="source">
class: center, middle, inverse, title-slide

# Dynamism and Complexity in Immune Ecology
## Undertstanding the rules that govern lymphocyte dynamics across our lifespan
### 
### Sanket Rane
### 2022-02-01

---

class: center, middle









count: false
layout: false

&lt;video autoplay width="100%" height="100%" controls id="my_video"&gt;
    &lt;source src="figures/Presentation1.mp4" type="video/mp4"&gt;
&lt;/video&gt;
---

## .center[Peculiar problem]

&lt;hr&gt;

&lt;img src="figures/slide3.png" width="90%" style="display: block; margin: auto;" /&gt;



---
class: inverse
background-image: url("figures/inverse_bg.png")

### Three fundamental laws of Golemics:

- &lt;h3 style="color:#fcba03; font-size:130%"&gt; Unique and specific: &lt;/h3&gt;
 
  - Each Golem uniquely identifies an unknown trait. 
 
  - Large army for countless possibilities.


--

- &lt;h3 style="color:#fcba03; font-size:130%"&gt; Aware of self:  &lt;/h3&gt;
  
  - Each Golem must Recognize our own.
  
  - Any that pose threat to earth inhabitants are removed instantly. 


--

- &lt;h3 style="color:#fcba03; font-size:130%"&gt; React, multiply and Remember: &lt;/h3&gt;
  
  - Once an alien trait is identified react.
  
  - Make more copies of yourself.
  
  - Remember the trait to respond faster next time.



---
class: inverse, center, middle
background-image: url("figures/inverse_bg.png")

## .center[The Golems of our immune system]

&lt;img src="figures/intro_eco.png" width="90%" style="display: block; margin: auto;" /&gt;

---

## .center[T and B cells are cornerstones of adaptive immunity]
&lt;hr&gt;


### * Unique and Specific: 

- Repertoire of clones that identify proteins and lipids  &amp;rarr; collectively called as **antigens**, that are expressed on pathogens and tumors.

--

- Each clone carries a unique receptor.
  &gt; T cells express T cell receptor (TCR). &lt;/br&gt;
  &gt; B cells express antibody molecules (Ig).

--

- T and B cells that havent encountered antigen yet &amp;rarr;  **Naive** cells.
  &gt; Continuously circulate within lymphatic and blood circulation in search of "specific antigens".

---

&lt;hr&gt;


### * Aware of self: 

- Educated in the BM, thymus and spleen to identify self-antigens.

- Clones that `recognize` self are **selected positively.** 

- Clones that `recognize` and `react` are removed through **negative selection.**

--

&lt;br&gt;

.shadedbox2[

&amp;#x1F4A1; Interesting insight

Over 95% newly made T cells and B cells are removed from  during their development by the processes of positive and negative selection.

This ensures that the lymphocytes entering our lymphatic and blood circulation are only specific to foreign and unknown antigens.
]  
  
---

### * React and Remember: 

- Effector response against pathogens and tumors by secreting Antibodies, Cytokines, Interferons etc.

--

- Proliferate massively to make more antigen specific clones.

--

- Transform into **memory** cells for future encounters.

--


&lt;h3 style="color:#9e423c;"&gt;
A broad and long-lasting  T and B cell repertoires are crucial to protect against &lt;strong&gt;new&lt;/strong&gt; and &lt;strong&gt;recurring&lt;/strong&gt; infections throughout our lifetime.
&lt;/h3&gt;

???
Maintaining the size and breadth of naive T cell repertoire is paramount in protecting us against new infections throughout our lifetime.

---

class: center, middle, inverse


## How are the numbers and clonal diversity of lymphocyte populations maintained throughout life?






---



## .center[Dynamic ecosystem]

&lt;hr&gt;

&lt;img src="figures/intro_eco2.png" width="100%" style="display: block; margin: auto;" /&gt;


???

Compartments shaped by constant influx of new specificities, loss of old ones…

- b and t cells with new specificities are continuously exported from BM and Thymus into the peripheral lymphoid organs as , which slowly mature into are basically young naive T cells.

- The clonal diversity and numbers of peripheral naive t cells are maintained by an aggregate effect of death, division and differentiation processes.

- In many ways it is an ecosystem - We need to quantify lymphocyte ecology to understand the development and maintenance of our immune repertoires.


&lt;!---
## .center[Dynamic ecosystem]

&lt;hr&gt;


&lt;img src="figures/intro_eco1.png" width="100%" style="display: block; margin: auto;" /&gt;

--&gt;

---

## Immune ecology
&lt;hr&gt;


&lt;h3&gt;
* Lymphocyte repertoires are
&lt;/h3&gt; 

- augmented by flow of new cells from the bone marrow &lt;span style="color:#035AA6;"&gt; &amp;#8594; enhances diversity.&lt;/span&gt;

--
  
- sustained by proliferation (homeostatic self-renewal) &lt;span style="color:#035AA6;"&gt; &amp;#8594;skews diversity&lt;/span&gt;
  
--


- depleted by loss of cells (by death and onward differentiation).

--

&lt;h3 style="color:#9e423c;"&gt;
Can we quantify all of these processes to understand how the repertoire is established and how it evolves over an individual’s lifespan?
&lt;/h3&gt; 

---

### Complexity &amp; Dynamism in lymphocyte homeostasis

&lt;hr&gt;



#### Multiple processes contribute to **establishment** and **maintenance**.  
&lt;/h3&gt;

 - Division, death, influx from the precursor, onward differentiation etc.


&lt;img src="figures/homeostasis_processes.png" width="55%" style="display: block; margin: auto;" /&gt;


--


### Does the relative contribution of these processes vary across a lifetime?


---

### What happens with age?
&lt;hr&gt;

- #### Dynamic growth in early life
  
  - Newly generated lymphocytes quickly populate and adapt to rapidly developing tissues.
  
  - Naive T and B cell numbers change dramatically up to puberty in humans and age 7-8 weeks in mice.


--


- #### Stability in Adulthood
  - Numbers are maintained stably despite decline in production.
  - Is there compensatory increase in cell division or decrease in loss or both?
  
&lt;/br&gt;


.right[
&lt;p style="font-size:90%; color:#595959;"&gt;Verheijen et al. 2020, Rane et al. Plos Bio 2018,  &lt;/br&gt; Duchamp et al. Imm Infl Dis 2014,  den Braber et al. Immunity 2012, Bains et al. JI 2009,  &lt;/p&gt;
]

---
&lt;hr&gt;

### Potential mechanisms that may compensate decline in production.

- **Quorum sensing**
&gt; Cells compete for reources that are necessary for their persistence. &lt;/br&gt;
&gt; Decrease in population density triggers increased survival and division.

--

&lt;/br&gt;

- **Adaptation**
&gt; Cells adapt to survive longer and/or to divide better with their age. &lt;/br&gt;
&gt; Accumulation of &lt;span style="color:#9e423c;"&gt;old &lt;/span&gt; cells as we age.

--

&lt;/br&gt;

- **Selection**
&gt; Natural variation in cellular fitness. &lt;/br&gt;
&gt; Some clones persist longer than others and accumulate as we age.

---

### What are the rules of replacement within lymphocyte populations? 
&lt;hr&gt;

#### Is replacement purely stochastic? Hierarchy? 

???
- Random displacement? Hierarchy? 

--

-  First-in-first-out  &amp;rarr; Conveyor belt?  

- First-in-**last**-out?

--

Identifying these rules impacts our understanding of diversity maintenance



???

- Do new immigrants displace pre-existing cells or the relatively older cells have a 'homeostatic advantage'?


--


### &amp;rArr; Are lymphocyte restoration therapies beneficial?
  - HSC transplant, lymphoablative procedures, Immunodeficiencies  and HIV patients

--

### &amp;rArr; Does heightened vulnerability to infections and cancer with age stem from accumulation of &lt;span style="color:#9e423c;"&gt; old &lt;/span&gt; and potentially &lt;span style="color:#9e423c;"&gt; incompetent &lt;/span&gt; cells over time?




---
class: inverse
background-image: url("figures/inverse_bg.png")

## .center[Building unifying models of T and B cell life-histories]
&lt;hr&gt;

### A single model that explains it all &amp;mdash;  &lt;/br&gt; 

--

&lt;h3 style="color:#fcba03; font-size:150%;"&gt;
&amp;#8658; Dynamic establishment in neonates and stability in adults. 
&lt;/h3&gt;

--

&lt;h3 style="color:#fcba03; font-size:150%;"&gt;
&amp;#8658; How and why does our immunity wanes with age?
&lt;/h3&gt;

???
Do changes in the age-structure and diversity of naive T cells explain why our ability to fight new infections wanes with age?

--

&lt;h3 style="color:#fcba03; font-size:150%;"&gt;
&amp;#8658; Evolution of lymphocyte repertoires and  collapse in its diversity with age.
&lt;/h3&gt;

???

&lt;h3 style="color:#fcba03; font-size:150%;"&gt;
&amp;#8658; Prediction of lymphocyte recovery in Stem cell transplant and HIV patients.

???
So, mostly through this work we want to study the Mechanisms that regulate T cell pool sizes and in turn their clonal diversity across our lifespans.
**A model that explains it all** &amp;xrarr; 

- How cd4 and cd8 repertoire evolve and how different they are

--

### .center[A quantitative map of our immune competence.]

???
Our goal is to understand the deterministic processes behind naive T cell maintenance and then use it simulate how TCR repertoire diversity evolves using gillespie algorithm or agent based models.

Also knowledge of thse mechanisms will definitly help us to understand how T cell pools are reconstituted in HSC Transplants and in HIV patients

&lt;!---
?Is there LIP? Does the extent of reconstitution depend on the age of individual?
---&gt;







---



class: center;

### Temporal fate mapping: A window into lymphocyte dynamics
&lt;hr&gt;

### Immune chimerism using Bone marrow transplants in  mice


&lt;img src="figures/BUCHI_diag.jpg" width="80%" style="display: block; margin: auto;" /&gt;

--

### Tracking  &lt;span style="color:#9e423c;"&gt;invasion&lt;/span&gt; of donor cells into the host compartments over time.

???
We have devised a novel exp strategy to temporally map cellular replacement in mice using this drug called busulfan.

now busulfan specifically targets actively dividing cells and kills them.
We have optimised a low dose of busulfan that targets HSCs while leaving the peripheral lymphocyte compartments intact.

then in these busulfan treated mice we transfer BM from congenic donors and track the donor and host cells over a year!!!!

---

### Dynamics of 4 crucial components of adaptive immune system

&lt;hr&gt;

1. **Naive CD4 T cells**

  - "Helper T cells" &amp;rarr; provide instructive signals to other T cells and B cells.
  
--
  
2. **Naive CD8 T cells**

  -  "Killer T cells" &amp;rarr; deliver cyto-toxic signals to pathogens and tumors.
  
--
  
3. **Follicular B cells**

  - "Conventional B cells" &amp;rarr; secrete high-affinity antibodies.
  
--

  
4. **Marginal Zone B cells **

  - "Gatekeepers of the immune system" &amp;rarr; eliminate blood-borne pathogens.
  

---
count: false

class: center, middle, inverse;

## What are the rules of naive T cell homeostasis?



---
class: center, middle;

### Dynamics of naive CD4 and CD8 T cells in adult busulfan chimeric mice

&lt;hr&gt;

&lt;/br&gt;


&lt;img src="figures/counts_data.png" width="90%" style="display: block; margin: auto;" /&gt;

.right[
&lt;p style="font-size:90%; color:#595959;"&gt;
Different colors indicate different ages when BMT was performed.
&lt;/p&gt;
]

&lt;hr&gt;


---

### Niche sizes are aggregates of production and turnover
&lt;hr&gt;


.pull-left[

&lt;img src="figures/homeostasis_processes.png" width="120%" style="display: block; margin: auto;" /&gt;

]

.pull-right[

.center[
&lt;p style="font-size:90%"&gt; 
Neutral model: constant rates
&lt;/p&gt;


$$
\dot{N} = \phi \, P(t) + \rho \, N - \delta \, N
$$

$$
\dot{N} = \phi \, P(t) + \psi \, M 
$$
&lt;p style="font-size:90%; color:#595959"&gt; 
P: upstream precursor population.
&lt;/p&gt;
]
]

--

&lt;br&gt;


`\(\psi\)` is the net growth rate:  
 the propensity of a cell for division minus its propensity for loss `\((\rho - \delta)\)`

--

&lt;br&gt;

#### The ability of a cell and its progeny to persist within the compartment over time — ‘Homeostatic fitness'.

&lt;hr&gt;

???
and we can express this mathematically in a simplest model like this ...

to simplify further... we can combine the cells ability to divide and turnover into one single parameter `\(\psi\)`.
Now e just have 2 parameters!!! Voila!
We're always looking to tie the maths to biological reality - you can interpret the inverse of phi as the average
lifetime of a clone, rather than a single cell.

---

class: center
### The kinetics of percolation of donor cells are rich in information

&lt;hr&gt;

&lt;/br&gt;


&lt;img src="figures/Nfd_data.png" width="90%" style="display: block; margin: auto;" /&gt;

---
count:false

class: center
### The kinetics of percolation of donor cells are rich in information

&lt;hr&gt;

&lt;/br&gt;



&lt;img src="figures/chi_cartoon.png" width="90%" style="display: block; margin: auto;" /&gt;


&lt;p&gt;
&lt;span style="font-weight:bold"&gt;Set point – &lt;/span&gt;  Whether replacement is complete or incomplete. &lt;/br&gt;
&lt;span style="color:#006789"&gt; Heterogeneity within the compartment.&lt;/span&gt;
&lt;/p&gt;

&lt;p&gt;
&lt;span style="font-weight:bold"&gt;Upslope – &lt;/span&gt; How fast host cells are replaced by donor-BM-derived cells. &lt;/br&gt;
&lt;span style="color:#006789"&gt;  Driven by the rate of influx and growth. &lt;/span&gt; 



---
### Untangling division and loss
&lt;hr&gt;


- `\(\small \text{Ki}67\)` — a nuclear protein expressed during cell-division.&lt;/br&gt;
&amp;#8618; Independent handle on the rate of cell division.

--

- Lymphocytes continue to express Ki67 protein for &amp;approx; 4 days after the division.
.right[
&lt;span style="color:#606060; font-weight:900; font-size:90%;"&gt; Hogan _et. al._, PNAS 2015&lt;/span&gt;
]


&lt;img src="figures/ki67_untangle.png" width="30%" style="display: block; margin: auto;" /&gt;


### Residual signal from development or homeostatic division in periphery?


&lt;hr&gt;

---

class: center
### Division history of naive T cells

&lt;hr&gt;

&lt;/br&gt;


&lt;img src="figures/Ki_data.png" width="90%" style="display: block; margin: auto;" /&gt;


---


### Potential mechanisms of lymphocyte maintenance
&lt;hr&gt;

#### Quorum sensing

  &gt; Competition for survival or self-renewal



&lt;img src="figures/QS_diag.png" width="45%" style="display: block; margin: auto;" /&gt;

--

&lt;br&gt;

.shadedbox[
$$
\frac{dN}{dt} = \phi \, P(t) + \rho(N) \, N(t) - \delta(N) \, N(t)
$$
.center[P(t): Changes in counts of immediate precursor populations.]
]

---

&lt;hr&gt;

#### Kinetic heterogeneity
  
  &gt; Two compartments with distinct rates of division and loss
  
&lt;img src="figures/KH_diag.png" width="45%" style="display: block; margin: auto;" /&gt;

--

.shadedbox[
$$
`\begin{aligned}
&amp;\frac{dR}{dt} = \phi \, P(t) + \rho_1 \, N(t) - \delta_1 \, N(t) \\
&amp;\frac{dM}{dt} = \mu \, R(t) + \rho_2 \, N(t) - \delta_2 \, N(t)
\end{aligned}`
$$
]

&lt;hr&gt;

---

&lt;hr&gt;

#### Adaptation: Cell-age dependence
  
  &gt; Ability to die or self-renew modifies with cell-age.
  
&lt;img src="figures/asm_diag.png" width="50%" style="display: block; margin: auto;" /&gt;

--

Naive T cells of age 'a' and Ki67 expression 'k' are tracked across time 't', by analytically solving a 3-dimensional PDE,

.shadedbox[
$$
`\begin{aligned}
\frac{\partial N}{\partial t} + \frac{\partial N}{\partial a} - \beta \, k \, \frac{\partial N}{\partial k}= -(\rho(a) + \delta(a)) \, N(t, a, k)
\end{aligned}`
$$
]

&lt;hr&gt;
---
count: false

class: center, middle, inverse

## How to select the best model?

---
class: center

### Model validation
&lt;hr&gt;

$$
`\begin{aligned}
&amp;y_i \sim \text{normal}(\mu_i, \sigma_i) \quad \quad \quad \quad \quad \quad  &amp;[\text{likelihood}] \\
&amp;\mu_i = M(\text{time}, \theta)  &amp;[\text{model prediction}]\\
\end{aligned}`
$$
`\(\theta:\)` Vector of parameters within the model.

--



.shadedbox[
$$
`\begin{aligned}
&amp; \small \text{log(Total counts) } \Rightarrow \quad &amp;y_1 \sim \text{normal}(\mu_1, \sigma_1)\\
&amp; \small \text{logit(Normalised donor fraction) } \Rightarrow \quad &amp;y_2 \sim \text{normal}(\mu_2, \sigma_2)
\end{aligned}`
$$
]

--

&lt;h3 style="font-size:140%; color:#9e423c;"&gt;  Prior  distributions are defined for model parameters &amp;rarr;   &amp;theta;'
&lt;/h3&gt;

$$
`\begin{aligned}
\text{For example, } \quad \quad
&amp;\theta_1 \sim \text{uniform}(0.0, 1.0)  \\
&amp;... \\
&amp;\theta_n \sim \text{normal}(0.005, 0.01)  \\
\end{aligned}`
$$



???

Each model was fitted simultaneously to the timecourses of `\(\small log(\text{counts})\)`   proportions of `\(\small logit(\text{Ki}67^{high})\)` cells.



We form a joint likelihood which is the probability density of data across the parameter distribution `\(\theta\)` by assuming that the errors are normally distributed. 

---

&lt;hr&gt;

### Our aim is to update prior beliefs in the model:  `\(\quad \theta'\)` &amp;rarr; `\(\hat\theta\)`


$$
P(\hat \theta | y_1, y_2) = \frac{P(y_1 | \hat \theta) \cdot P(y_2 | \hat \theta)  \cdot P(\theta')}{P(y_1) \cdot P(y_2) } 
$$
--

&lt;/br&gt;

### Sampling the posterior:
Parameters are sampled from the joint density `\(P(\theta)\)` using **Hamiltonian Monte Carlo** (H-MC) algorithm.

  - Models are coded in _Stan_ language and fitted using the **NUTS** sampler.
  - Posterior distributions and model fits are analyzed using _R_ package `rstan`. 
  
&lt;hr&gt;
???
Normalized product of probability densities of both datasets and the prior distribution of params.

- This probability density is then used to update our prior beliefs in model parameters using the bayesian approach.


We judge the models under consideration based on **parsimony** and their ability to predict **New observations** which is also called as out of sample prediction error.


.shadedbox2[
Occam's razor:
Models are selected based on **parsimony** and their ability to predict **New observations** &amp;mdash; (out-of-sample prediction error).
]


---
### Estimate of **confidence** in the model
&lt;hr&gt;


### Leave-One-Out cross validation:

&lt;img src="figures/looic.png" width="40%" style="display: block; margin: auto;" /&gt;


$$
\text{Leave-One-Out information criterion:} \,\,
\small \text{LooIC} = -2 \,\, \sum_{i=1}^n \, Z_i
$$

.center[
&lt;h3 style="color:#9e423c; font-size:150%;"&gt;
&amp;#8658; LooIC measures the model's ability to predict new data.
&lt;/h3&gt;
]


.right[... continued]


???
We measure this  out of sample prediction error using Leave-One-Out cross validation, in which a single observation is treated as test dataset and rest of the observations are trated as training data. The process is repeated for all 'n' observations and the prediction error for each left-out test set is aggregated to calculate Leave-One-Out information criterion (LOOIC).


---
&lt;hr&gt;

### Scaling the models:

$$
\small \Delta \text{LooIC} = \text{LooIC}_i - \text{min}(\text{LooIC})
$$

  - `\(\small \Delta \text{LooIC} = 0 \Rightarrow\)` Best-fit model. 
  - Higher values suggest poorer support from the data.

???
Only relative values of LooIC are meaningful

--

&lt;/br&gt;

### Relative support:

&lt;u&gt;Analog of Akaike weight&lt;/u&gt;

.shadedbox[
$$
\omega_i = \frac{\exp(-\frac{1}{2} \, [\Delta \text{LooIC}]_i)}{\sum_m^M  \, \exp(-\frac{1}{2} \, [\Delta \text{LooIC}]_m)}
$$
]

- Proportional statistical support among the models under consideration.

???
We then used the estimated LOO-IC values to assess the relative support for models using the analog of the Akaike weight which gives us the probability that a given model will explain new data better than other models considered in this analysis.


---
class: center, top

### Naive T cells **adapt** to persist longer in circulation
&lt;hr&gt;

&lt;img src="figures/cd4_fit.png" width="85%" style="display: block; margin: auto;" /&gt;



---
class: center, top

### Naive T cells **adapt** to persist longer in circulation
&lt;hr&gt;

&lt;img src="figures/cd8_fit.png" width="85%" style="display: block; margin: auto;" /&gt;


???


### Results

&lt;hr&gt;

using buchi data and statisical validation we found:

1. neutral and quorum sensing models could be rejected.

2. Equivocal support for Adaptation and selection models.

---

&lt;hr&gt;

### Next steps:

- We refined our models to pinpoint whether cell-age dependent effects manifest in either their rate of **loss** (&amp;delta;) or their rate of **division** (&amp;rho;)

--

- Equivocal support for age-dependent loss &amp;delta;(a) and  age-dependent division &amp;rho;(a) models.

--

&lt;br&gt;

### Uncertainty in model selection may arise from:

1. Sparsity in observations.

2. Batch effects and experimental variations.

3. Poorly defined models - Oversimplified or too complex.

&lt;hr&gt;
---

### How do we then select the best-fitting model?

--

- #### Assess the parameter estimates from each model.

&gt; Non-physiological parameters may warrant reanalysis or optimization of model definitions. 

--

- #### Add more **relevant** data to fitting procedures. 

&gt; Adding more steady-state data points may not influence the model behavior. &lt;/br&gt;
&gt; Break the models by testing them against systemic perturbations.

--

- #### Make out-of-sample predictions. 

&gt; Assess models' ability to predict data generated in diverse experimental settings.


---
### Validating models using out-of-sample predictions approach
&lt;hr&gt;

&lt;img src="figures/pnas1.png" width="70%" style="display: block; margin: auto;" /&gt;

&lt;img src="figures/houston_diag.png" width="65%" style="display: block; margin: auto;" /&gt;

.right[
&lt;p style="font-size:90%; color:#595959;"&gt;Houston et al. PNAS 2011&lt;/p&gt;]

--

### We generated predictions of the survival kinetics of naive T cells using cell-age dependent models.


---
class: center

### Expected lifespan of naive CD4 and CD8 T cells increases with cell-age.
&lt;hr&gt;


Ratio of &lt;span style='color:#B13B7F;'&gt;young&lt;/span&gt; and &lt;span style='color:#3B57B1;'&gt;old&lt;/span&gt; cells

&lt;img src="figures/houston_d.png" width="55%" style="display: block; margin: auto;" /&gt;


&lt;p style="font-size:120%; color:#9e423c;"&gt;
Age-dependent division &amp;rho;(a) model failed to explain the survival kinetics of naive T cells.
&lt;/p&gt;

---


### Predicting T cell dynamics in early life
&lt;hr&gt;

### Rag&lt;sup&gt;GFP&lt;/sup&gt; Ki67&lt;sup&gt;RFP&lt;/sup&gt; mouse model

- GFP is expressed in developmental stages in the Thymus and is turned off upon export to the peripheral lymphoid organs.

- T cells in periphery dilute GFP by,
&gt; cellular ageing: exponential decline as GFP gets degraded within cells.
&gt;
&gt; cell-division: GFP is distributed equally between progeny.


---
class: center, top

### Out-of-sample predictions of naive T cell dynamics in early life

&lt;hr&gt;

&lt;img src="figures/Ontogeny_preds2.png" width="75%" style="display: block; margin: auto;" /&gt;


--

### Distinct dynamics of naive CD8 T cells in neonates and adults.

&lt;hr&gt;


---

class: center, middle

### Naive CD8 T cells are lost at a faster rate in neonates than in adults.

&lt;hr&gt;

&lt;img src="figures/Hostage_ASM.png" width="85%" style="display: block; margin: auto;" /&gt;


&lt;br&gt;

&lt;hr&gt;

??? 
Simple out of sample prediction method revelaed a very profound principle of naive cD8 t cell dynamics -- 

---

class: center, middle

### The adaptation model provides the most parsimonious explanation of naive T cell maintenance
&lt;hr&gt;

&lt;br&gt;

&lt;style type="text/css"&gt;
caption {
      color: #035AA6;
      font-weight: bold;
      font-size: 1.25em;
    }
&lt;/style&gt;

&lt;table class="table" style="font-size: 15px; margin-left: auto; margin-right: auto;"&gt;
&lt;caption style="font-size: initial !important;"&gt;Table: Summary of results&lt;/caption&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Dataset &lt;/th&gt;
   &lt;th style="text-align:center;"&gt; Neutral &lt;/th&gt;
   &lt;th style="text-align:center;"&gt; Competition &lt;/th&gt;
   &lt;th style="text-align:center;"&gt; Selection &lt;/th&gt;
   &lt;th style="text-align:center;"&gt; Adaptation &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Cell counts in Wild Type mice &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✔ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✔ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✔ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: green !important;"&gt; ✔ &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Cell counts in Thymectomised mice &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✗ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✔ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✔ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: green !important;"&gt; ✔ &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;color: darkblue !important;"&gt; Dynamics in Busulfan BM chimeras &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkblue !important;font-weight: bold;color: darkred !important;"&gt; ✗ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkblue !important;font-weight: bold;color: darkred !important;"&gt; ✗ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkblue !important;font-weight: bold;color: darkred !important;"&gt; ✔ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkblue !important;font-weight: bold;color: green !important;"&gt; ✔ &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Kinetics of adoptively transferred cells &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✗ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✗ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✗ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: green !important;"&gt; ✔ &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Naive T cell acccumulation in early life &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✗ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✗ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; — &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: green !important;"&gt; ✔ &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Decline of in vivo labelled naive T cells &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; — &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; ✗ &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; — &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: green !important;"&gt; ✔ &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Dynamics of newly made cells in neonates and adults &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; — &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; — &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: darkred !important;"&gt; — &lt;/td&gt;
   &lt;td style="text-align:center;font-weight: bold;color: green !important;"&gt; ✔ &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

.right[
Rane _et. al._ Plos Bio 2018 and bioR&amp;chi;iv 2022 
]
---

### Insights into naive T cell homeostasis
&lt;hr&gt;


1. Naive T cells **divide rarely**.
  
  - Inter-division times for:
  
    &gt; -  CD4 T cells &amp;approx; 18 mo (CI: 16-22)
    &gt; -  CD8 T cells &amp;approx; 14 mo (CI: 12-26)
  
--

2. Their **life-expectancy** increases with cell-age.
  
  - Mean lifespan of youngest cells:
  
    &gt; - CD4 T cells &amp;approx; 3 wk (CI: 2.5-4)
    &gt; - CD8 T cells &amp;approx; 3 mo (CI: 2.5-4.5)

  - Time taken for lifespan to double: 
   
    &gt; - CD4 T cells &amp;approx; 6 wk (CI: 5-7)
    &gt; - CD8 T cells &amp;approx; 5 mo (CI: 3.5-7)
    
    
&lt;hr&gt;
    
    
    
    
    
    
    
  



---




class: center, inverse

# .center[B cell ecology]

&lt;hr&gt;

&lt;br&gt;

--

## How are different B cell subsets maintained over time? 

--

&lt;br&gt;

## What are the pathways of B cell differentiation? 


???
I will focus on Fm B cells ... they emerge from Tr cells. quant. aspects of the lineage transitions and branchppoints are still unclear. 

 ### .center[Very little is known about the quantitative aspects B cell homeostasis]
 
 is T1 T2 source for FMS? are they homog?
how long do they reside for on average? 

- ### Do the rules of their turnover and replacement change with age? 

---

class: top, center
## Development of B lymphocytes
&lt;hr&gt;


&lt;img src="figures/lymphoid_dev.jpg" width="80%" style="display: block; margin: auto;" /&gt;


???

Parallels between B and T cell development

Pro - Pre - selection and division - Immature B cells exit to periphery

End of the world post apocalyptic scenario
you are an engineer and the fate of the world depends on how you make this one weapon that selectively neutralizes the aliens invading our planet

???

---

## B cell maturation in the spleen
&lt;hr&gt;

- B cells transition through **short-lived** developmental stages in the spleen.


- Late-stage transitional (T2) B cells bifurcate into fully mature Follicular (FO) or Marginal Zone (MZ) B cells.

&lt;br&gt;


&lt;img src="figures/bcell_matu.jpg" width="60%" style="display: block; margin: auto;" /&gt;

---

## Division of labour and space
&lt;hr&gt;

&lt;!---
#### Division of labour within B cells
---&gt;

&lt;h4 style="color:#006789; font-size:100%"&gt; 
Marginal Zone is an anatomical barrier that divides lymphocyte-rich follicles and the erythrocyte-rich red pulp.
&lt;/h4&gt;

.pull-left[
&lt;img src="figures/MZ_viz1.jpg" width="100%" style="display: block; margin: auto;" /&gt;

.right[*Zimber-Strobl group* 
&lt;p style="font-size:90%; color:#595959;"&gt;Lechner et al Nat Comm 2021 &lt;/p&gt;
]

]

???
5 % of circulation goes through spleen
blood cicrulation opens into marginal sinus where blood slows down so that Mphages and B cells guarding the sinus can filter it for antigens/pathogens.

--

.pull-right[


- FO B cells typically respond to antigens presented by Dendritic cells and Macrophages in a **T cell dependent manner** and produce high-affinity antibodies.
{{content}}

]


???

MZ B cells are strategically positions to locate pathogens that breach systemic barrier and emerge in blood.

--


- MZ B cells are strategically positioned to identify and respond to **blood-borne** antigens. 
&lt;h4 style="color:#9e423c;"&gt;&amp;#8658; Gatekeepers of the immune system.&lt;/h4&gt;


---

## .center[Complete replacement within FO B cell pool]

.middle[
&lt;img src="figures/FM_data.png" width="90%" height="90%" style="display: block; margin: auto;" /&gt;
]


???
- minor and gradual increase in cell counts

- Complete replacement --&gt; homogeneous 

- donor Ki67 looks higher- suggests host and donor not acting in same way - so how can it be homog?

We again to Maths to reconcile these obs./ anomalies

---

class: center, middle

## FO B cells turn over more slowly with host age

&lt;img src="figures/Results_FM_T1.png" width="90%" style="display: block; margin: auto;" /&gt;

???
inter div time for both donor and host is SAME! booth rarley divide most of the ki67 is inherited.

This naturally explains there host; donor diffs in Ki67 - NOT ANY INTRINSIC HOST/DONOR DIFFS - RATHER,  soon after BMT the donor cells in the FM pool have all recently entered from the T1 pool, who are rapidly dividing -  so will be transiently enriched for cell that inhertityed ki67. But over time as the population turns over, host and donor look same. And there is actually very  little division within FM cells. 

---
class: 

### Insights into FO B cell homeostasis
&lt;hr&gt;


- FO B cells divide **very rarely.**
  - Inter-division times &amp;approx;  &gt; 1 year (CI: 0.6-23)
  
  
--

&lt;br&gt;

- Their **life-expectancy** increases with mouse age.
  - Mean lifespan in a
    &gt; 10 wk old mouse &amp;approx;  35 days (CI: 2.5-4) &lt;/br&gt;
    &gt; 1 year old mouse &amp;approx;  45 days &lt;/br&gt;
    &gt; 2 year old mouse &amp;approx;  61 days


 
--

&lt;br&gt;

### FO B cells are a homogeneous, slowly dividing population whose lifespan increases with host age

???

inter div time for both donor and host is SAME! booth rarley divide most of the ki67 is inherited.

This naturally explains there host; donor diffs in Ki67 - NOT ANY INTRINSIC HOST/DONOR DIFFS - RATHER,  soon after BMT the donor cells in the FM pool have all recently entered from the T1 pool, who are rapidly dividing -  so will be transiently enriched for cell that inhertityed ki67. But over time as the population turns over, host and donor look same. And there is actually very  little division within FM cells. 

---

### Plasticity in B cell differentiation pathways
&lt;hr&gt;


&lt;br&gt;

&lt;img src="figures/bcell_matu.jpg" width="50%" style="display: block; margin: auto;" /&gt;

???

### BCR signalling strength is believed to be the deciding factor.
Strong signals drive differentiation into FO and weak signals lead to MZ fate. 
  
---
count: false

### Plasticity in B cell differentiation pathways
&lt;hr&gt;

&lt;br&gt;

&lt;img src="figures/bcell_matu2.jpg" width="50%" style="display: block; margin: auto;" /&gt;


- Fully mature follicular (FO) and very early stage transitional (T1) B cells can also  develop into MZ B cells depending on the **Notch2** signal availability.
.right[
##### Lechner *et al.* Nat Comm 2021
]

???

### Factors governing B cell fate-determination remain unknown.  


---
count: false

class: middle
&lt;hr&gt;

## How do B cells integrate Notch2 signals to determine cell-fate at steady states?

&lt;hr&gt;

---

### Cell fate determination in B cells
&lt;hr&gt;

- **Competition** for development?

  - Developing B cells compete for limiting concentration of Notch2 ligands.

--

- **Selection** across natural variation in Notch2 expression?
  - B cells that receive strong self-antigen:BCR signals up-regulate Notch2 and acquire MZ fate.
  
--
.center[
### `&lt;&lt; Insert answere here &gt;&gt;`
]


---

class: inverse
### What we learned about modelling?

&lt;blockquote&gt;
All models are wrong but some are useful.
.right[-- &lt;cite&gt;George Box&lt;/cite&gt;]
&lt;/blockquote&gt;

--

- Break the models by introducing system perturbations.

&lt;br/&gt;

--

### What we learned about lymphocyte biology?

- Life-expectancy of naive CD4 and CD8 T cells increases with their age.

- Naive CD8 T cells exhibit distinct dynamics in early life and adulthood.

- FO B cells are a homogeneous population whose lifespan increases with host age.

---
count: false
class: center

### Acknowledgements
&lt;hr&gt;

.pull-left[
#### University College London
Dr. Benedict Seddon &lt;/br&gt;
Dr. Melissa Verheijen
]

.pull-right[
#### Helmholtz Zentrum München
Dr. Ursula Zimber-Strobl &lt;/br&gt;
Dr. Lothar Strobl &lt;/br&gt;
Tea Babushku
]


#### Columbia University
Dr. Andrew Yates

--


&lt;/br&gt;

### A big thanks to **IICD** family!


&lt;img src="figures/CancerLogo.png" width="70%" style="display: block; margin: auto;" /&gt;


---
count: false
class: center, middle

&lt;img src="figures/Thanks.png" width="100%" height="60%" style="display: block; margin: auto;" /&gt;

# Thanks!

Slides were created in `html5` using [remark.js](https://remarkjs.com) and R packages [**knitr**](http://yihui.name/knitr) and [**xaringan**](https://github.com/yihui/xaringan).



    </textarea>
<style data-target="print-only">@media screen {.remark-slide-container{display:block;}.remark-slide-scaler{box-shadow:none;}}</style>
<script src="https://remarkjs.com/downloads/remark-latest.min.js"></script>
<script>var slideshow = remark.create({
"highlightStyle": "github",
"highlightLines": true,
"countIncrementalSlides": false
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function(d) {
  var s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})(document);

(function(d) {
  var el = d.getElementsByClassName("remark-slides-area");
  if (!el) return;
  var slide, slides = slideshow.getSlides(), els = el[0].children;
  for (var i = 1; i < slides.length; i++) {
    slide = slides[i];
    if (slide.properties.continued === "true" || slide.properties.count === "false") {
      els[i - 1].className += ' has-continuation';
    }
  }
  var s = d.createElement("style");
  s.type = "text/css"; s.innerHTML = "@media print { .has-continuation { display: none; } }";
  d.head.appendChild(s);
})(document);
// delete the temporary CSS (for displaying all slides initially) when the user
// starts to view slides
(function() {
  var deleted = false;
  slideshow.on('beforeShowSlide', function(slide) {
    if (deleted) return;
    var sheets = document.styleSheets, node;
    for (var i = 0; i < sheets.length; i++) {
      node = sheets[i].ownerNode;
      if (node.dataset["target"] !== "print-only") continue;
      node.parentNode.removeChild(node);
    }
    deleted = true;
  });
})();
(function() {
  "use strict"
  // Replace <script> tags in slides area to make them executable
  var scripts = document.querySelectorAll(
    '.remark-slides-area .remark-slide-container script'
  );
  if (!scripts.length) return;
  for (var i = 0; i < scripts.length; i++) {
    var s = document.createElement('script');
    var code = document.createTextNode(scripts[i].textContent);
    s.appendChild(code);
    var scriptAttrs = scripts[i].attributes;
    for (var j = 0; j < scriptAttrs.length; j++) {
      s.setAttribute(scriptAttrs[j].name, scriptAttrs[j].value);
    }
    scripts[i].parentElement.replaceChild(s, scripts[i]);
  }
})();
(function() {
  var links = document.getElementsByTagName('a');
  for (var i = 0; i < links.length; i++) {
    if (/^(https?:)?\/\//.test(links[i].getAttribute('href'))) {
      links[i].target = '_blank';
    }
  }
})();
// adds .remark-code-has-line-highlighted class to <pre> parent elements
// of code chunks containing highlighted lines with class .remark-code-line-highlighted
(function(d) {
  const hlines = d.querySelectorAll('.remark-code-line-highlighted');
  const preParents = [];
  const findPreParent = function(line, p = 0) {
    if (p > 1) return null; // traverse up no further than grandparent
    const el = line.parentElement;
    return el.tagName === "PRE" ? el : findPreParent(el, ++p);
  };

  for (let line of hlines) {
    let pre = findPreParent(line);
    if (pre && !preParents.includes(pre)) preParents.push(pre);
  }
  preParents.forEach(p => p.classList.add("remark-code-has-line-highlighted"));
})(document);</script>

<script>
slideshow._releaseMath = function(el) {
  var i, text, code, codes = el.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
};
slideshow._releaseMath(document);
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
